Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) just unveiled an announcement.
Concord Healthcare Group Co., Ltd. has established a Nomination Committee under its Board of Directors to streamline the selection and appointment process for directors and senior management. The committee, composed mainly of independent non-executive directors, is tasked with setting procedures and standards, conducting candidate evaluations, and advising the board. This move aims to enhance corporate governance and ensure qualified leadership within the company.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$2.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the healthcare industry. The company is listed on the Hong Kong Stock Exchange and focuses on the selection and appointment of directors and senior management, adhering to corporate governance standards and regulations.
Average Trading Volume: 5,461,772
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.04B
Learn more about 2453 stock on TipRanks’ Stock Analysis page.